{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:01:50Z","timestamp":1786737710943,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Reprod Sci"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/jhrs.jhrs_69_20","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T11:30:24Z","timestamp":1616931024000},"page":"94","source":"Crossref","is-referenced-by-count":1,"title":["Chemotherapy can interfere in implantation in in-vitro fertilization"],"prefix":"10.4103","volume":"14","author":[{"given":"Parul","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Banker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jwal","family":"Banker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-1208.312451-1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"key-10.4103\/0974-1208.312451-2","doi-asserted-by":"crossref","unstructured":"Santorsola D, Abruzzese E. Successful management of pregnancy and hepatic toxicity in a CML female patient treated with nilotinib: a case report and a review. Mediterranean journal of hematology and infectious diseases. 2015;7(1); DOI: http:\/\/dx.doi.org\/10.4084\/MJHID.2015.020","DOI":"10.4084\/mjhid.2015.020"},{"key":"key-10.4103\/0974-1208.312451-3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-8722-2-42","article-title":"Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: Case study","author":"Conchon","year":"2009","journal-title":"J Hematol Oncol"},{"key":"key-10.4103\/0974-1208.312451-4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: The prospective, multicenter Stop Imatinib (STIM) trial","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"},{"key":"key-10.4103\/0974-1208.312451-5","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1080\/10428194.2018.1551533","article-title":"The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia","author":"Lasica","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"key-10.4103\/0974-1208.312451-6","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1182\/blood-2007-10-114900","article-title":"The effects of imatinib on pregnancy outcome","author":"Pye","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0974-1208.312451-7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3816\/CLM.2009.n.064","article-title":"Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: A case report and review of the literature","author":"Cole","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"key-10.4103\/0974-1208.312451-8","unstructured":"Abruzzese E, Trawinska MM, Perrotti AP, De Fabritiis P. Tyrosine kinase inhibitors and pregnancy. Mediterranean Journal of Hematology and Infectious Diseases. 2014;6(1)., DOI: http:\/\/dx.doi.org\/10.4084\/MJHID.2014.028s"},{"key":"key-10.4103\/0974-1208.312451-9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/17474086.2016.1205479","article-title":"Management of pregnant chronic myeloid leukemia patients","author":"Abruzzese","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"key-10.4103\/0974-1208.312451-10","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41598-019-39134-0","article-title":"Imatinib treatments have long-term impact on placentation and embryo survival","author":"Salem","year":"2019","journal-title":"Sci Rep"},{"key":"key-10.4103\/0974-1208.312451-11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5505\/tjh.2012.82542","article-title":"Imatinib use in pregnancy","author":"Webb","year":"2012","journal-title":"Turk J Haematol"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:58:16Z","timestamp":1786733896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.JHRS_69_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["312451"],"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_69_20","relation":{},"ISSN":["0974-1208"],"issn-type":[{"value":"0974-1208","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}